The Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for obinutuzumab (Gazyva®) for the treatment of lupus nephritis.

GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, ...

CARLSBAD, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today reported financial results for the fourth quarter and full year ended ...

Uniklinikum Erlangen at Friedrich-Alexander-Universität Erlangen-Nürnberg has successfully treated more than 45 people with autoimmune diseases using ...

基于上述理由，羟氯喹的日剂量根据实际体重计算，每日最多 5 mg/kg，且不超过400 mg。有条件检测羟氯喹的血药浓度，则尽量控制在 500~2000 ng/mL[9]；但需注意每日使用羟氯喹 3~6 个月后的血药浓度最准确。每年可检查 1~2 次 ...

Reynier Hidalgo González, a young Cuban from Báguano in Holguín province, has taken to social media to share his ...

Patients with SLE vs individuals without autoimmune disease demonstrated higher rates of peripartum complications.

“We are trying to maintain patient programs, but we need funding to do it and that is why the walk is so important," said ...